Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints
Adam Buckley, E. Louise Thomas, Nader Lessan, et al.
Diabetes Research and Clinical Practice (2018) Vol. 144, pp. 144-152
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
Jianghua Zhou, Jingjing Cai, Zhi‐Gang She, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 11, pp. 1307-1326
Open Access | Times Cited: 207
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al-Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 10
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States
Pegah Golabi, James M. Paik, Jessica Hwang, et al.
Liver International (2018) Vol. 39, Iss. 4, pp. 748-757
Closed Access | Times Cited: 54
Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism
Zhongyang Lu, Yanchun Li, Wing‐Kin Syn, et al.
AJP Endocrinology and Metabolism (2019) Vol. 318, Iss. 2, pp. E131-E144
Open Access | Times Cited: 39
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review
Noriko Shinjyo, James R.C. Parkinson, Jimmy D. Bell, et al.
Journal of Integrative Medicine (2020) Vol. 18, Iss. 2, pp. 125-151
Open Access | Times Cited: 34
ALT poorly predicts Nonalcoholic Fatty Liver Disease (NAFLD) and liver fibrosis as determined by vibration-controlled transient elastography in adult National Health and Nutrition Examination Survey 2017–2018
Sally Condon, Huirong Hu, Maiying Kong, et al.
The American Journal of the Medical Sciences (2024) Vol. 367, Iss. 5, pp. 310-322
Closed Access | Times Cited: 4
BRCA1 regulates glucose and lipid metabolism in diabetes mellitus with metabolic dysfunction-associated steatotic liver disease via the PI3K/Akt signaling pathway
Cui Ma, Xiaodi Yang, Liyin Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0318696-e0318696
Open Access
The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease
Christian von Loeffelholz, Johannes Roth, Sina M. Coldewey, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1853-1853
Open Access | Times Cited: 25
A novel dipeptide from potato protein hydrolysate augments the effects of exercise training against high-fat diet-induced damages in senescence-accelerated mouse-prone 8 by boosting pAMPK / SIRT1/ PGC-1α/ pFOXO3 pathway
Marthandam Asokan Shibu, Ting Wang, Ming-Fu Wang, et al.
Aging (2020) Vol. 12, Iss. 8, pp. 7334-7349
Open Access | Times Cited: 23
Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
Fang Lei, Xiaoming Wang, Changquan Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
Yuan Li, E-er-man-bie-ke Jin-si-han, Cheng Feng, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 9, pp. 1263-1273
Closed Access | Times Cited: 2
Effects of Unfiltered Coffee and Bioactive Coffee Compounds on the Development of Metabolic Syndrome Components in a High-Fat-/High-Fructose-Fed Rat Model
Pedram Shokouh, Per Bendix Jeppesen, Kjeld Hermansen, et al.
Nutrients (2018) Vol. 10, Iss. 10, pp. 1547-1547
Open Access | Times Cited: 15
Therapeutic Effects of Morinda citrifolia Linn. (Noni) Aqueous Fruit Extract on the Glucose and Lipid Metabolism in High-Fat/High-Fructose-Fed Swiss Mice
Aline Carla Inada, Gabriela Torres Silva, Laleska Pâmela Rodrigues da Silva, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3439-3439
Open Access | Times Cited: 13
Association of nonalcoholic fatty liver disease and carotid media‐intima thickness: A systematic review and a meta‐analysis
Manouchehr Khoshbaten, Sepideh H. Maleki, Sara Hadad, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 4
Deep Learning With Ultrasound Images Enhance the Diagnosis of Nonalcoholic Fatty Liver
Yao Liu, Wenrou Yu, Peizheng Wang, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 11, pp. 1724-1730
Closed Access | Times Cited: 1
Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD)
Wei Xia, Ning Yang, Yuming Li
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 11
Nonalcoholic fatty liver disease and diabetes
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, et al.
World Journal of Diabetes (2022) Vol. 13, Iss. 9, pp. 668-682
Open Access | Times Cited: 7
No association between aortic stiffness and liver steatosis in morbidly obese patients
Grzegorz Styczyński, Piotr Kalinowski, Łukasz Michałowski, et al.
Atherosclerosis (2019) Vol. 287, pp. 165-170
Closed Access | Times Cited: 7
Rosuvastatin and co-enzyme Q10 improve high-fat and high-fructose diet-induced metabolic syndrome in rats via ameliorating inflammatory and oxidative burden
Mohamed I. Fahmy, Rabab H. Sayed, Muhammad Farag El-Yamany, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113526-113526
Open Access | Times Cited: 4
Non-alcoholic fatty liver disease and cardiovascular diseases: features of the comorbid course
T. М. Bentsa
Medicine of Ukraine (2020), Iss. 1 (237), pp. 44-47
Open Access | Times Cited: 4
The Association between Fatty Liver Index and Lower Limb Arterial Calcification in Patients with Type 2 Diabetes Mellitus
Peibiao Mai, Qilong Li, Sijin Li, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 10
Open Access
Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
José León, Enric Sánchez, F Herrerias, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Nonalcoholic Fatty Liver Diseases in Newly Analyzed Diabetes Mellitus Patients with Risk Factors
Ayzaz Ismail, Jahangir Anjum, Hammad ur Rehman Bhatti, et al.
(2022) Vol. 16, Iss. 4, pp. 570-572
Open Access | Times Cited: 2
Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
Guglielmo M. Trovato
World Journal of Gastrointestinal Pathophysiology (2020) Vol. 11, Iss. 3, pp. 57-63
Open Access | Times Cited: 2
Analysis of Metabolic Biomarkers in Non-Alcoholic Fatty Liver Disease (NAFLD); A Comprehensive Review
Shagufta Akhtar, Azhar U. Khan
Advanced Journal of Graduate Research (2020) Vol. 9, Iss. 1, pp. 46-58
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top